Skip to content
  • Saturday, 12 September 2026
  • 5:51 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • UK Health Watchdog Drafts Against Routine NHS Funding for Gilead’s Twice-Yearly HIV Prevention Injection Lenacapavir
Pharmaceutical R&D

UK Health Watchdog Drafts Against Routine NHS Funding for Gilead’s Twice-Yearly HIV Prevention Injection Lenacapavir

Teuku Ryan Sep 11, 2026 0

The National Institute for Health and Care Excellence (NICE) has issued a preliminary recommendation against the routine NHS commissioning of…

Read More
Pharmaceutical R&D

UK Life Sciences Sector Faces Funding Crisis Despite Government Prioritisation

Teuku Ryan Jul 7, 2026 0

The United Kingdom’s ambitious plans to foster growth within its vital life sciences sector are facing significant headwinds, with industry…

Read More
Pharmaceutical R&D

The Biotech Sector Navigates a Shifting Landscape of Funding, Regulation, and Innovation

Teuku Ryan Jun 19, 2026 0

Following a significant investment slump that began after the initial surge of capital during the early COVID-19 pandemic, the biotechnology…

Read More
Pharmaceutical R&D

SpliSense Advances Promising Cystic Fibrosis Therapy with Significant Funding and Phase IIb Trial Launch

Teuku Ryan Jun 17, 2026 0

The biotech firm SpliSense is making significant strides in the development of a novel therapy for cystic fibrosis, announcing a…

Read More
Pharmaceutical R&D

Europe Must Rethink Funding and De-Risk Assets to Secure its Rare Disease Research Pipeline

Teuku Ryan Jun 13, 2026 0

The 13th European Conference on Rare Diseases and Orphan Products, held in Prague, Czech Republic, from June 3-4, 2026, served…

Read More
Pharmaceutical R&D

Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials

Teuku Ryan Jun 3, 2026 0

Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…

Read More
Pharmaceutical R&D

Protuoso Biosciences Secures $9.5 Million Seed Funding to Pioneer Multifunctional Biologics for Complex Diseases

Teuku Ryan May 27, 2026 0

Protuoso Biosciences, a burgeoning US-based biotechnology company, has successfully closed a $9.5 million seed financing round, positioning itself to revolutionize…

Read More
Pharmaceutical R&D

Isomorphic Labs Secures $2.1 Billion in Series B Funding to Accelerate AI-Driven Drug Discovery and Development

Teuku Ryan May 14, 2026 0

AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…

Read More
Pharmaceutical R&D

Ray Therapeutics Secures $125 Million Series B Funding to Accelerate Vision Restoration Pipeline

Teuku Ryan Apr 22, 2026 0

Ray Therapeutics, a biopharmaceutical company at the forefront of developing novel gene therapies for vision restoration, has successfully closed a…

Read More
Biotech & Genetic Research

Cancer Scientists Unite at AACR Annual Meeting, Send Powerful Message to Congress on Sustained Research Funding

Jia Lissa Apr 22, 2026 0

On Sunday morning at the San Diego Convention Center, every attendee seated in Hall H for the Opening Ceremony and…

Read More

Posts pagination

1 2
Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis TreatmentViz.ai and Alnylam Forge Strategic Alliance to Revolutionize Cardiac Amyloidosis Diagnosis and CareCERN Researchers Identify Potential Cracks in the Standard Model Following Unprecedented Observations at the Large Hadron ColliderCity skylines influence cloud formation above them
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
TWiV 1287: Ancient herpesviruses and modern dementiaJohns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid DropletsRNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancersMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
YOU MAY HAVE MISSED
Microbiology & Immunology
TWiV 1287: Ancient herpesviruses and modern dementia
Lina Irawan Sep 12, 2026
Stem Cell & Regenerative Medicine
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ